ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
Abroad (travel likely)RecruitingPHASE2
Conditions
NSCLC (Advanced Non-small Cell Lung Cancer) · EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China